CURE

Calendar of CURE/Yale BioHaven seminars for Fall 2010 now available. more

9/14
8:45 am - 6:00 pm
Ubifrance, the French Agency for international business development, cordially invites CURE members to this year's second French Biotech Tour, which aims to connect French and American Biotech companies specialized in neuroscience, inflammation, and auto-immune diseases. Philadelphia, PA. more

9/16
6:00 pm - 7:30 pm
CURE/Yale BioHaven presents Al Mann: 'Creating a successful medical device enterprise.' Hope Auditorium, Yale University, 315 Cedar Street, New Haven. more

10/5
Deadline for nominations for the Lemelson-MIT prize, awarded to an outstanding mid-career inventor who has developed a patented product or process of significant value to society. more

10/27
4:00 pm - 6:00 pm
CURE/Yale BioHaven presents Cobalt Therapeutics. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more

11/18
4:00 pm - 6:00 pm
CURE/Yale BioHaven presents Biodel Inc. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more

12/7
5:30 pm - 7:30 pm
CURE Holiday Party. Café George, 300 George Street, New Haven. Watch for details.

AsymmetRx, Inc.
117 Senate Brook Drive
Amston, CT 06231

Phone: 860-716-8888
Fax: 860-413-4333

Contact(s)
Maria McKeon, President - mckeon@asymmetRx.com

General Information
AsymmetRx, Inc. is a drug discovery company with discoveries in the areas of depression, blindness and cancer. Its founders include scientists from Harvard University School of Medicine (Frank McKeon, Ph.D.) and Johns Hopkins University School of Medicine (Jun Liu, Ph.D.). The company has exclusive rights to patents relating to drug compounds from Harvard and Johns Hopkins. The company has also received 510(k) clearance from the FDA for a prostate cancer diagnostic test "Prostate-63 Cander Diagnostic Test" which is being used extensively in the diagnostic market. AsymmetRx, Inc. has the exclusive rights from Harvard for the p63 gene and antibodies to it for cancer diagnostics (prostate, breast, etc.).